Spontaneous intra-cerebral hemorrhage: A retrospective study of risk factors and outcome in a Turkish population

Introduction

Cerebrovascular diseases are the third leading cause of death after heart disease and cancer in developed countries. They also come first in terms of causing death and disability in neurologic diseases in adults.[1]

Spontaneous intra-cerebral hemorrhage (ICH), which is defined as spontaneous rupture of the intra-cerebral small vessels following cerebral vessel wall degeneration due to frequent chronic hypertension or rarely to cerebral amyloid angiopathy, has an incidence of 15-19/100,000/year and a 30-day mortality of 40-50%.[2] The risk factors for ICH are identified as hypertension, advancing age, male sex, excessive alcohol intake, anticoagulation therapy, smoking, and diabetes.[2345] To determine these risk factors is very important in terms of developing preventative measures.

We aimed to determine the risk factors for spontaneous ICH in a Turkish population retrospectively, and study the effects of these factors on mortality as well as applied therapeutic strategies on survival.

Materials and Methods

Results

The demographic and clinical features of the patients are summarized in Table 1. Bleeding localization in the patients was determined as 95 (89.6%) for supratentorial and 11 (10.4%) for infratentorial. In the supratentorial hemorrhage group, 51 (48.1%) patients bled in the cortex, 1 (0.9%) bled in the subcortical white matter, 42 (39.6%) bled in the basal ganglions and 1 (0.9%) in the capsula interna while in the infratentorial group, 10 (9.4%) patients bled in the cerebellum and 1 (0.9%) in the brainstem. In terms of bleeding volumes 50 (47.2%) patients had small (0-9.9 cm³), 37 (34.9%) had medium (10-29.9 cm³), 15 (14.2%) had large (30-59.9 cm³), and 4 (3.8%) patients had very large (≥60 cm³) hemorrhages.

Table 1 The demographic and clinical features of patients

We found that mortality increased with older age (P = 0.043), advancing bleeding volume (P < 0.001), development of ventricular extension of hemorrhage (P = 0.001), the presence of midline shift (P < 0.001), but not with gender (P > 0.05) or the development of subarachnoidal extension of hemorrhage (P > 0.05). However, there was no significant association between mortality and anti-aggregant and/or anticoagulant drug usage (P > 0.05) [Table 2].

Table 2 Determinative factors affecting mortality

Due to the significant effect on mortality, we adjusted the logistic regression models for age variable. In univariate analysis, we found increased mortality with advancing bleeding volume (P = 0.001), development of ventricular extension of hemorrhage (P < 0.001), the presence of midline shift (P < 0.001), and warfarin usage (P < 0.05). In multivariate analysis, being over 65 years (P < 0.05), advancing bleeding volume (P < 0.05) and the presence of midline shift (P < 0.05) were found as independent factors on mortality. Both univariate and multivariate analyses were summarized in Table 3. There was also no significant difference between anti-aggregant/anti-coagulant medication and bleeding volume (P > 0.05) [Table 4].

Table 3 Comparison of variables on mortality

Table 4 Association between medication and bleeding volume

In a total of 106 patients, medical treatment was applied to 74 (69.8%) patients, whereas surgical treatment was given to 32 (30.2%). Thirty seven (34.9%) patients in total died in hospital. In addition, 30 (81%) of the deaths were in the 1^st month (early mortality) and 7 (18.9%) occurred after 1 month (late mortality). Seven of nine patients with complications of systemic and infectious diseases, died in the 1^st month. We also found that patients who were given surgical therapy showed a longer survival rate (P = 0.016); however, no association was found between medical and surgical therapy in terms of mortality (P = 0.555) [Figure 1a and b] and clinical differences (P > 0.05) [Table 5].

Close

Figure 1

Comparison of exitus status (a) and exitus time (b) between treatment groups

Export to PPT

Table 5 Clinical differences between treatment groups

Discussion

There have been several publications on the hemorrhagic strokes; however, we aimed to determine the risk factors for spontaneous ICH in a Turkish population retrospectively. The salient findings of our study were as follows: (i) In those over the age of 65, increased hemorrhage volume, having ventricular extension of hemorrhage and the presence of midline shift were demonstrated as the determinative factors affecting mortality; (ii) uncontrolled blood pressure levels were found to be the most common risk factor leading to cerebral hemorrhage; (iii) the surgical treatment group showed a longer survival rate compared to patients who were given medical treatment.

Age was known as the most important unchangeable risk factor for spontaneous ICH. Ariesen et al., Sturgeon et al., and Efstathiou et al., have reported that older age was a major risk factor for ICH.[2710] In the present study, the mean age was determined as 62.5 accompanied by the finding that mortality was observed to be higher in patients over the age of 65. This is in accordance with the literature. A decrease in vessel elasticity with aging makes the vessel wall vulnerable to the effects of hypertension; this may be the hypothetic mechanism for increased risk of cerebral hemorrhage and result in with worse outcomes. Male sex, especially being over the age of 55, has been described as another risk factor for spontaneous ICH in the literature. While the meta-analysis of Ariesen et al., supported this belief, no association was found in the reports of Sturgeon et al., and Efstathiou et al.[2710] Gender was in favor of males in our study group.

The importance of hypertension in spontaneous ICH etiology has been already pointed out in the studies of Sacco, Ariesen et al., and Woo et al.[125] In one study with 152 cases, hypertension was found in 73% of patients.[11] In another series involving 141 patients, hypertension was determined in 83% of patients.[4] In our study group, hypertension was determined in 78 patients (73.5%). The number of patients with uncontrolled blood pressure levels was found as 69.2% among hypertensive patients in spite of antihypertensive treatment. This result is remarkable in that it underlines the importance of effective blood pressure control in the prevention and management of ICH. Recently, antihypertensive treatment of acute cerebral hemorrhage II study group confirmed the efficacy and safety of early, intensive acute antihypertensive treatment, providing evidence of attenuation of hematoma expansion with intensive systolic blood pressure reduction, in subjects with spontaneous ICH.[12]

With respect to mortality, Delgado et al., and Castellanos et al., found the mortality as 20% and 28.3% respectively.[1314] In this study, the mortality rate was determined as 34.9% (37 patients) and 81% (30 patients) of deaths were observed in the 1^st month (early mortality), whereas early mortality relating to ICH was about 35-50% in the literature.[15] Likewise, Hemphill et al., reported 30-day mortality as 45% in their study.[11] In our study, it was very surprising that early mortality was found at higher levels; a possible explanation may be confounding systemic diseases or opportunistic infections. As a matter of fact, 9 of the 37 patients who died during hospitalization were found to have complications with infectious, pulmonary and hematologic issues and seven of them died in the 1^st month. Therefore, it should be kept in mind that these systemic pathologic courses may influence morbidity and mortality in a negative direction in the course of evaluating patients with ICH.

In the literature, bleeding volume has been shown as an important factor that affects mortality. Cheung and Zou, found the hematoma volume was statistically higher in the dead group than in the recovering group.[4] Similar results were obtained in the studies of Castellanos et al.[14] Likewise, parallel results were achieved from different studies.[111316] In line with previous data, we found a significant association between bleeding volume and mortality. Another determinative factor for mortality was subarachnoidal extension of hemorrhage in ICH as reported previously.[4] However, we did not find a relation in our study. This might be due to fewer patients in defined group. Other significant factor was shown to be ventricular extension of hemorrhage. Cheung and Zou, Hemphill et al. and Delgado et al. reported concomitance of ventricular extension of hemorrhage with increased mortality radiologically in their studies.[41113] Similarly, we found that the mortality rate was higher in patients with ventricular extension than in those who did not. The presence of midline shift has also been defined as another determinative factor on mortality in ICH.[17] In a series with 141 patients, the presence of shift was found in 83.9%.[4] In agreement with the literature, in the present study, 59.1% of patients with shift and 17.7% of those without shift, were found to die. In the literature, there are a few studies examining the association between mortality and anti-aggregant/anti-coagulant usage. In a study of 435 patients performed by Rosand et al., the mortality rate was found to be significantly higher in the group using warfarin (52%) than in those who did not (25.8%).[18] In contrast, we did not find a significant association between anti-aggregant/anti-coagulant medication and mortality. This might be due to another finding that indicates no significant difference between advanced bleeding volume and medication types. Another possible explanation may have been the small size of the group. In their recent study, Flaherty et al., also reported that warfarin usage caused a significant increase in hematoma volume in the group whose International Normalized Ratio values were over three among patients using warfarin.[19] In our study, among these factors being over 65 years, advancing bleeding volume and the presence of midline shift were found as independent factors on mortality. Overall, determinative factors affecting mortality were almost similar in European, Asian studies and those from United States with different ethnic backgrounds.[247] Although not unique or undescribed, our results confirm the previous reports in a Turkish perspective. Because we aimed to study the risk factors, especially related to the prognosis of ICH patients with medical and/or surgical therapy, we designed the study in a clinical manner rather than epidemiological.

Studies on treatment modalities (medical/surgical) have revealed conflicting results with regard to patients with supratentorial hemorrhages. The superiority of surgical treatment over medical has been much emphasized in recent trials because of its benefits such as decreasing intracranial pressure by lessening hematoma volume; thus, restoring perfusion in the surrounding tissue and helping to remove toxic products despite the unfavorable effects such as the risk of causing parenchymal tissue damage and influencing functional recovery in a negative direction.[20] Whereas in another prospective, international, multicenter clinical study published by Mendelow et al. named surgical trial of ICH, similar results displaying no benefit for surgery were obtained in two groups receiving surgical and medical treatment for “disability” and “mortality with 6 months” end points.[21] In other randomized controlled studies in which minimal invasive surgical techniques were used, no definitive result was obtained.[2223] In comparing treatment modalities, we found that patients who were given surgical therapy showed a longer survival rate; however, no association was found between medical and surgical therapy in terms of mortality and clinical differences. This might be related to the quality of care services after surgery during hospitalization. As a matter of fact, unconscious patients with ICH and those went to surgical treatment were hospitalized on intensive care unit of which concept was to provide systematic prevention of complications through specialized nursing care and appropriate monitoring as well as early rehabilitation.[24] Whereas the rest were followed-up on regular neurological ward settings having lower resource utilization conversely as mentioned by Epifanov et al.[25]

This study has some potential limitations. First, the sample size is relatively small, mainly due to the fact that the participants were selected from a single institute. Second, it is retrospective. Third, although Glasgow coma scale is an important determinant of outcome, we could not able to provide this data from retrospective analysis. Fourth, despite the serial high measurements of blood pressure and serum glucose levels in follow-up, hypertensive or diabetic conditions still might be masked because of low blood pressure or serum glucose measurements on admission during the acute phase. Fifth, it might be the paucity of discharge data and absence of advanced imaging.

In conclusion, early detection and pharmacological rapid control of hypertension is the key intervention to decrease the incidence of this devastating type of stroke. Future genetic and epidemiologic studies will help identify at-risk populations and hopefully allow for primary prevention. Randomized, controlled studies focusing on novel therapeutics should aid in minimizing secondary injury and hopefully improve morbidity and mortality.